| 1 |
Mostafalou S, Abdollahi M. Pesticides and human chronic diseases: evidence, mechanisms, and perspectives. Toxicol Appl Pharmacol. 2013; 268(2): 157-77.
|
| 2 |
DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med. 2003; 348(26): 2656-68.
|
| 3 |
Murakami K, Sakamoto K, Ishiguchi H, Ito H. Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes diagnosed after metformin-triggered stroke-like episodes. J Stroke Cerebrovasc Dis. 2023; 32(5): 107080.
|
| 4 |
Parikh S, Goldstein A, Karaa A, Koenig MK, Anselm I, Brunel-Guitton C, et al. Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2017; 19(12). DOI:10.1038/gim.2017.107.
|
| 5 |
Nakasaki H, Ohta M, Soeda J, Makuuchi H, Tsuda M, Tajima T, et al. Clinical and biochemical aspects of thiamine treatment for metabolic acidosis during total parenteral nutrition. Nutrition. 1997; 13(2):110-7.
|
| 6 |
Kamel KS, Oh MS, Halperin ML. L-lactic acidosis: pathophysiology, classification, and causes; emphasis on biochemical and metabolic basis. Kidney Int. 2020; 97(1): 75-88.
|
| 7 |
Yu HB, Cheng Y, Xu M, Song YQ, Luo YM, Li B. Synthesis, acaricidal activity, and structure-activity relationships of pyrazolyl acrylonitrile derivatives. J Agric Food Chem. 2016; 64(51): 9586-91.
|
| 8 |
Zheng X, Huang M. A rare case of MELAS syndrome caused by mitochondrial DNA m.3256C>T mutation in China. World J Emerg Med. 2025; 16(2):180-2.
|
| 9 |
DiMauro S, Hirano M. Mitochondrial encephalomyopathies: an update. Neuromuscul Disord. 2005; 15(4): 276-86.
|
| 10 |
Ikawa M, Povalko N, Koga Y. Arginine therapy in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Curr Opin Clin Nutr Metab Care. 2020; 23(1): 17-22.
|
)
